Physician profile
David A Samuels
NPI 1487653622
$3,257.70
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $539 · 2020: $321 · 2021: $132 · 2022: $625 · 2023: $149 · 2024: $1,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $750 · Consulting Fee: $600 · Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $750.00 |
| Consulting Fee | $600.00 |
| Food and Beverage | $291.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $750.00 | 2024 | |
| Abbott Laboratories | $634.93 | 2019-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Alexion Pharmaceuticals, INC. | $600.00 | 2024 | Ultomiris |
| Cti Biopharma Corp. | $450.00 | 2022 | |
| Medtronic Vascular, INC. | $156.82 | 2020 | |
| Acutus Medical, INC. | $134.64 | 2019 | |
| Biotronik INC. | $113.60 | 2020 | |
| Seagen INC. | $105.31 | 2019 | |
| Astellas Pharma US INC | $76.01 | 2019-2024 | Xtandi |
| Takeda Pharmaceuticals U.S.A., INC. | $66.50 | 2022-2023 | Livtencity |
| Amgen INC. | $60.25 | 2019-2020 | |
| G Medical Diagnostic Services, INC. | $39.98 | 2019 | |
| Heartflow, INC. | $36.53 | 2019 | |
| Pfizer INC. | $17.41 | 2023 | |
| Janssen Pharmaceuticals, INC | $15.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Samuels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.